204 related articles for article (PubMed ID: 36108734)
1. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
[TBL] [Abstract][Full Text] [Related]
2. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of impaired reactivity in the corpus cavernosum of STZ-diabetic rats by slow-release H
Qabazard B; Yousif MHM; Phillips OA
Int J Impot Res; 2019 Mar; 31(2):111-118. PubMed ID: 30302015
[TBL] [Abstract][Full Text] [Related]
4. GYY4137 attenuates functional impairment of corpus cavernosum and reduces fibrosis in rats with STZ-induced diabetes by inhibiting the TGF-β1/Smad/CTGF pathway.
Qabazard B; Yousif M; Mousa A; Phillips OA
Biomed Pharmacother; 2021 Jun; 138():111486. PubMed ID: 34311523
[TBL] [Abstract][Full Text] [Related]
5. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery.
Chitnis MK; Njie-Mbye YF; Opere CA; Wood ME; Whiteman M; Ohia SE
Exp Eye Res; 2013 Nov; 116():350-4. PubMed ID: 24145109
[TBL] [Abstract][Full Text] [Related]
7. [The role of hydrogen sulfide in acute lung injury during endotoxic shock and its relationship with nitric oxide and carbon monoxide].
Huang XL; Zhou XH; Wei P; Xian XH; Ling YL
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2240-5. PubMed ID: 19087669
[TBL] [Abstract][Full Text] [Related]
8. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous hydrogen sulfide in nerve-evoked relaxation of pig terminal bronchioles.
Fernandes VS; Recio P; López-Oliva E; Martínez MP; Ribeiro AS; Barahona MV; Martínez AC; Benedito S; Agis-Torres Á; Cabañero A; Muñoz GM; García-Sacristán A; Orensanz LM; Hernández M
Pulm Pharmacol Ther; 2016 Dec; 41():1-10. PubMed ID: 27603231
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
Tang B; Ma L; Yao X; Tan G; Han P; Yu T; Liu B; Sun X
J Vasc Surg; 2017 Feb; 65(2):501-508.e1. PubMed ID: 26781077
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide donor, NaHS, stimulates ANP secretion via the K
Yu L; Park BM; Ahn YJ; Lee GJ; Kim SH
Peptides; 2019 Jan; 111():89-97. PubMed ID: 29684589
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H
Berenyiova A; Cebova M; Aydemir BG; Golas S; Majzunova M; Cacanyiova S
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012477
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen Sulfide Donor GYY4137 Acts Through Endothelial Nitric Oxide to Protect Intestine in Murine Models of Necrotizing Enterocolitis and Intestinal Ischemia.
Drucker NA; Jensen AR; Te Winkel JP; Markel TA
J Surg Res; 2019 Feb; 234():294-302. PubMed ID: 30527488
[TBL] [Abstract][Full Text] [Related]
16. Ginkgolide B increases hydrogen sulfide and protects against endothelial dysfunction in diabetic rats.
Wang GG; Chen QY; Li W; Lu XH; Zhao X
Croat Med J; 2015 Feb; 56(1):4-13. PubMed ID: 25727037
[TBL] [Abstract][Full Text] [Related]
17. Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats.
Velasco-Xolalpa ME; Barragán-Iglesias P; Roa-Coria JE; Godínez-Chaparro B; Flores-Murrieta FJ; Torres-López JE; Araiza-Saldaña CI; Navarrete A; Rocha-González HI
Neuroscience; 2013 Oct; 250():786-97. PubMed ID: 23830907
[TBL] [Abstract][Full Text] [Related]
18. Parenteral Na
Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
[TBL] [Abstract][Full Text] [Related]
19. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase.
Zhong G; Chen F; Cheng Y; Tang C; Du J
J Hypertens; 2003 Oct; 21(10):1879-85. PubMed ID: 14508194
[TBL] [Abstract][Full Text] [Related]
20. H
Li Y; Li L; Zeng O; Liu JM; Yang J
Ren Fail; 2017 Nov; 39(1):265-272. PubMed ID: 27882817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
